{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T02:28:02Z","timestamp":1777170482744,"version":"3.51.4"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.pnpbp.2008.01.018","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T15:04:29Z","timestamp":1202915069000},"page":"1030-1040","source":"Crossref","is-referenced-by-count":20,"title":["Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: Interactions with clozapine actions and attentional performance in rats"],"prefix":"10.1016","volume":"32","author":[{"given":"Amir H.","family":"Rezvani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Tizabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruk","family":"Getachew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheketha R.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Patrick","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward D.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2008.01.018_bib1","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1176\/ajp.150.12.1856","article-title":"Normalization of auditory physiology by cigarette smoking in schizophrenic patients","volume":"150","author":"Adler","year":"1993","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/oxfordjournals.schbul.a033320","article-title":"Schizophrenia, sensory gating, and nicotinic receptors","volume":"24","author":"Adler","year":"1998","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-007-0808-x","article-title":"Cognitive-disruptive effects of psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats","volume":"193","author":"Amitai","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/j.1440-1614.2006.01841.x","article-title":"Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use?","volume":"40","author":"Barnes","year":"2006","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(00)01614-1","article-title":"Tryptamine derivatives as non-competitive N-Methyl-d-aspartate receptor blockers: studies using [3H]MK-801 binding in rat hippocampal membranes","volume":"296","author":"Berger","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s002130050668","article-title":"Behavioral approaches to the assessment of attention in animals","volume":"138","author":"Bushnell","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130050446","article-title":"Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention","volume":"134","author":"Bushnell","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00115-004-1818-0","article-title":"Why do schizophrenic patients smoke?","volume":"76","author":"Cattapan-Ludewig","year":"2005","journal-title":"Nervenartz"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1037\/h0034213","article-title":"Personality variables associated with cigarette smoking","volume":"26","author":"Coan","year":"1973","journal-title":"J Pers Soc Psychol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-3806(97)00052-7","article-title":"Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging","volume":"101","author":"Court","year":"1997","journal-title":"Dev Brain Res"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib11","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1046\/j.1471-4159.1999.0731590.x","article-title":"Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus","volume":"73","author":"Court","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1176\/ajp.155.11.1490","article-title":"Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings","volume":"155","author":"Dalack","year":"1998","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1176\/ajp.153.3.417","article-title":"Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study","volume":"153","author":"Daniel","year":"1996","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.bcp.2006.12.004","article-title":"Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test","volume":"73","author":"Day","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib15","first-page":"31","article-title":"A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha4 and beta2 subunits and is up-regulated by chronic nicotine treatment","volume":"41","author":"Flores","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-1781(97)00062-0","article-title":"Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine","volume":"72","author":"Galletly","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib18","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/0924-977X(96)00010-7","article-title":"Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs","volume":"6","author":"Gallhofer","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1192\/bjp.162.1.43","article-title":"The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia","volume":"162","author":"Goldberg","year":"1993","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib20","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/schbul\/sbm074","article-title":"Molecular targets for treating cognitive dysfunction in schizophrenia","volume":"33","author":"Gray","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0091-3057(99)00259-2","article-title":"Nicotine enhances stimulus detection performance of middle- and old-aged rats: a longitudinal study","volume":"65","author":"Grilly","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.bjp.0702178","article-title":"Learning impairments induced by glutamate blockade using dizocilpine (MK-801) in monkeys","volume":"125","author":"Harder","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.neuroscience.2004.10.006","article-title":"Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor","volume":"130","author":"Hernandez","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/ajp.143.8.993","article-title":"Prevalence of smoking among psychiatric outpatients","volume":"143","author":"Hughes","year":"1986","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib25","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/oxfordjournals.schbul.a033374","article-title":"The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis","volume":"25","author":"Keefe","year":"1999","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/sj.npp.1300032","article-title":"Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex","volume":"28","author":"Lambe","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.pnpbp.2007.03.016","article-title":"Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients","volume":"31","author":"Lee","year":"2007","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/schbul\/22.3.431","article-title":"Nicotinic receptor function in schizophrenia","volume":"22","author":"Leonard","year":"1996","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/1568007023339102","article-title":"The promise of nicotinic treatment for cognitive dysfunction","volume":"1","author":"Levin","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib33","series-title":"Neurotransmitter interactions and cognitive function","first-page":"185","article-title":"Nicotinic\u2013antipsychotic drug interactions and cognitive function","author":"Levin","year":"2006"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02246281","article-title":"Nicotine effects on adults with attention-deficit\/hyperactivity disorder","volume":"123","author":"Levin","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0893-133X(96)00018-8","article-title":"Nicotine\u2013haloperidol interactions and cognitive performance in schizophrenics","volume":"15","author":"Levin","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0091-3057(98)00109-9","article-title":"Nicotine\u2013dizocilpine interactions and working and reference memory performance of rats in the radial-arm maze","volume":"61","author":"Levin","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.pnpbp.2005.01.012","article-title":"Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-d-aspartate (NMDA) glutamatergic receptor blockade","volume":"29","author":"Levin","year":"2005","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainres.2005.01.104","article-title":"Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding","volume":"1041","author":"Levin","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00213-005-0164-7","article-title":"Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification and anatomic localization","volume":"184","author":"Levin","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0079-6123(08)60502-6","article-title":"Prenatal adverse effects of nicotine on the developing brain","volume":"73","author":"Lichtensteiger","year":"1988","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4088\/JCP.v59n1005","article-title":"Clinical and neurocognitive effects of clozapine and risperidone in the treatment-refractory schizophrenics: a prospective study","volume":"59","author":"Lindenmayer","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib42","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/156802606777057599","article-title":"Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia","volume":"6","author":"Lindsley","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib43","first-page":"853","article-title":"Translational and developmental Perspective on N-methyl-d-aspartate synaptic deficits in schizophrenia","volume":"18","author":"MacDonald","year":"2006","journal-title":"Dev Psychopathol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1098-2299(199607\/08)38:3\/4<263::AID-DDR15>3.0.CO;2-#","article-title":"Smoking and schizophrenia","volume":"38","author":"McEvoy","year":"1996","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib45","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0006-3223(94)00365-A","article-title":"Clozapine decreases smoking in patients with chronic schizophrenia","volume":"37","author":"McEvoy","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib46","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1037\/0735-7044.112.6.1519","article-title":"Sustained attention performance in rats with intracortical infusions of 192 IgG-saporin-induced cortical cholinergic differentiation: effects of physostigmine and FG 7142","volume":"112","author":"McGaughy","year":"1998","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002130050991","article-title":"Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats","volume":"144","author":"McGaughy","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002130050671","article-title":"Nicotine enhances sustained attention in the rat under specific task conditions","volume":"138","author":"Mirza","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s002130000605","article-title":"Nicotine-induced enhancements in the five-choice serial reaction time task in rats are strain-dependent","volume":"154","author":"Mirza","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1586\/14737175.7.1.29","article-title":"Schizophrenia: more evidence for less glutamate","volume":"7","author":"Morrison","year":"2007","journal-title":"Expert Rev Neurotherapeutics"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib52","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0024-3205(87)90020-8","article-title":"Nicotine administration to rats: methodological considerations","volume":"40","author":"Murrin","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-3223(00)01125-2","article-title":"Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications","volume":"49","author":"Nordberg","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jnr.490310115","article-title":"Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia","volume":"31","author":"Nordberg","year":"1992","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hup.861","article-title":"Executive function in schizophrenia: what impact do antipsychotics have?","volume":"22","author":"O'grada","year":"2007","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib56","first-page":"9","article-title":"[3H]Cytisine binding to nicotinic cholinergic receptors in brain","volume":"39","author":"Pabreza","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00213-006-0584-z","article-title":"Long-term effects of developmental PCP administration on auditory gating in male and female rats","volume":"190","author":"Rasmussen","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib58","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0006-3223(00)01094-5","article-title":"Cognitive effects of nicotine","volume":"49","author":"Rezvani","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(03)01439-0","article-title":"Nicotine interactions with the NMDA glutaminergic antagonist dizocilpine and attentional function","volume":"465","author":"Rezvani","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0091-3057(03)00193-X","article-title":"Nicotine\u2013alcohol interactions and attentional performance on an operant visual signal detection task in female rats","volume":"76","author":"Rezvani","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2003.12.021","article-title":"Nicotine\u2013antipsychotic drug interactions and attentional performance in female rats","volume":"486","author":"Rezvani","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00213-002-1221-0","article-title":"Nicotine and mecamylamine effects on choice accuracy in an operant signal detection task","volume":"164","author":"Rezvani","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2003.12.021","article-title":"Nicotine\u2013antipsychotic drug interactions and attentional performance","volume":"486","author":"Rezvani","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib64","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-004-2060-y","article-title":"Nicotine\u2013serotonergic drug interactions and attentional performance in rats","volume":"179","author":"Rezvani","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib65","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pnpbp.2005.10.017","article-title":"Chronic nicotine interactions with clozapine and risperidone and attentional function in rats","volume":"30","author":"Rezvani","year":"2006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S1461145706007528","article-title":"Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats","volume":"11","author":"Rezvani","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0091-3057(94)90018-3","article-title":"Hyperactivity in the offspring of nicotine-treated rats: role of the mesolimbic and nigrostriatal dopaminergic pathways","volume":"47","author":"Richardson","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib68","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-0173(01)00044-3","article-title":"The cognitive neuroscience of sustained attention: where top-down meets bottom-up","volume":"35","author":"Sarter","year":"2001","journal-title":"Brains Res Rev"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib69","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pbb.2007.05.009","article-title":"Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats","volume":"87","author":"Semenova","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib70","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3565(24)29291-0","article-title":"The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat","volume":"299","author":"Stanhope","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib71","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1177\/070674379604100801","article-title":"Memory impairment in schizophrenia: perspectives from psychopathology and pharmacotherapy","volume":"41","author":"Stip","year":"1996","journal-title":"Can J Psychiatry"},{"issue":"3 Pt 1","key":"10.1016\/j.pnpbp.2008.01.018_bib72","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0013-7006(06)76162-0","article-title":"Cognition, schizophrenia, and the effects of antipsychotics","volume":"32","author":"Stip","year":"2006","journal-title":"Encephale"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib73","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(99)00886-9","article-title":"Nicotine in an animal model of attention","volume":"393","author":"Stolerman","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib74","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.301.1.284","article-title":"Effects of (\u00b1)-4-{[2-(1-methyl-2-pyrrolidinyl)ethyl]thio}phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys","volume":"301","author":"Terry","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib75","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF03033907","article-title":"Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia","volume":"12","author":"Tizabi","year":"2007","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib76","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s002130050879","article-title":"Antidepressant effects of nicotine in an animal model of depression","volume":"142","author":"Tizabi","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(99)01994-0","article-title":"Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions","volume":"851","author":"Trauth","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib78","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/sj.npp.1300745","article-title":"Nicotine normalizes increased prefrontal cortical dopamine D1 receptor binding and decreased working memory performance produced by repeated pretreatment with MK-801: a PET study in conscious monkeys","volume":"30","author":"Tsukada","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0006-3223(99)00272-3","article-title":"Familial transmission of risk factors in the first-degree relatives of schizophrenic people","volume":"47","author":"Waldo","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib80","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/syn.20267","article-title":"Facilitation of glutamate release by nicotine involves the activation of a Ca2+\/calmodulin signaling pathway in rat prefrontal cortex nerve terminals","volume":"15","author":"Wang","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib81","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-004-1940-5","article-title":"The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine","volume":"177","author":"Weiner","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib82","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1038\/sj.npp.1301385","article-title":"Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance","volume":"32","author":"Weiss","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.018_bib83","first-page":"246","article-title":"Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia","volume":"27","author":"Zhang","year":"2007","journal-title":"Neuropsychopharmacology"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T15:29:47Z","timestamp":1738078187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584608000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0278584608000468"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2008.01.018","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}